Kukje Pharma Co., Ltd. (KRX: 002720)
South Korea
· Delayed Price · Currency is KRW
5,540.00
+20.00 (0.36%)
Nov 15, 2024, 3:30 PM KST
Kukje Pharma Revenue
Kukje Pharma had revenue of 37.64B KRW in the quarter ending June 30, 2024, with 5.90% growth. This brings the company's revenue in the last twelve months to 142.60B, up 10.50% year-over-year. In the year 2023, Kukje Pharma had annual revenue of 135.37B with 6.94% growth.
Revenue (ttm)
142.60B
Revenue Growth
+10.50%
P/S Ratio
0.82
Revenue / Employee
572.68M
Employees
249
Market Cap
117.90B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 135.37B | 8.79B | 6.94% |
Dec 31, 2022 | 126.58B | 6.84B | 5.71% |
Dec 31, 2021 | 119.75B | -10.65B | -8.17% |
Dec 31, 2020 | 130.39B | 19.27B | 17.34% |
Dec 31, 2019 | 111.12B | 3.44B | 3.20% |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Dec 31, 2014 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full Definition